SciELO - Scientific Electronic Library Online

 
vol.27 número6Right atrial mass: The importance of cardiac ultrasound at the time of diagnosis of atrial fibrillation in the therapeutic approachUse of cardiovascular events prediction models for the prognosis of a severe coronary artery lesion índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Revista Colombiana de Cardiología

versão impressa ISSN 0120-5633

Resumo

HERNANDEZ, Keerby; PUCHULU, Juanita; ZAPATA, Margarita  e  RUZ, Miguel. Cardiac rhabdomyoma: Clinical presentation of three cases and current therapeutic options. Rev. Colomb. Cardiol. [online]. 2020, vol.27, n.6, pp.611-615.  Epub 04-Ago-2021. ISSN 0120-5633.  https://doi.org/10.1016/j.rccar.2019.12.011.

Up to a few decades ago, cardiac tumours were only of academic interest given their low presentation rate. However, with the advances in cardiopulmonary, surgical management began to be possible, and more recently, they contribute to the development of new treatment strategies for these patients.

The estimated incidence of cardiac tumours is low and are generally benign with non-specific clinical signs and symptoms. In paediatrics, these tumours are associated with tuberous sclerosis, a disease with a dominant autosomal inheritance pattern, which is characterised by an alteration in cell differentiation and multiplication (hamartomas) in different systems. From a cardiac point of view, the morbidity level is determined by the size and location of the tumour within the cavity, the risk of obstructing ventricular outflow tracts, alterations in valvular function, and conduction disorders. Some patients only require clinical follow-up all their lives, as there is the risk of tumour regression. Others may benefit from surgical resection due to its haemodynamic impact or changes in cardiac rhythm. However, not everyone is a candidate for surgery, in which case, management with m-TOR inhibitors has emerged as a therapeutic alternative.

The case is presented on three neonates with tuberous sclerosis and a cardiac rhabdomyoma, diagnosed in the prenatal stage. An individualised therapeutic approach was made based on the current options available for this group of patients.

Palavras-chave : Cardiac tumours; Rhabdomyoma; Everolimus; Newborn; Cardiac arrhythmias.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )